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Original Investigation

Comparison of Performance of Psychiatrists vs Other Outpatient Physicians
in the 2020 US Medicare Merit-Based Incentive Payment System
Andrew C. Qi, MD; Karen E. Joynt Maddox, MD, MPH; Laura J. Bierut, MD; Kenton J. Johnston, PhD

Abstract

Key Points

IMPORTANCE Medicare’s Merit-Based Incentive Payment System (MIPS) is a new, mandatory,
outpatient value-based payment program that ties reimbursement to performance on cost and
quality measures for many US clinicians. However, it is currently unknown how the program
measures the performance of psychiatrists, who often treat a different patient case mix with
different clinical considerations than do other outpatient clinicians.

Question How did psychiatrists
perform in the 2020 Medicare MeritBased Incentive Payment System (MIPS)
compared with other outpatient
physicians?
Findings In this cross-sectional study

OBJECTIVE To compare performance scores and value-based reimbursement for psychiatrists vs

of 9356 psychiatrists and 196 306 other

other outpatient physicians in the 2020 MIPS.

outpatient physicians participating in
the 2020 MIPS, psychiatrists had

DESIGN, SETTING, AND PARTICIPANTS In this cross-sectional study, the Centers for Medicare &

significantly lower performance scores,

Medicaid Services Provider Data Catalog was used to identify outpatient Medicare physicians listed in

were significantly more likely to be

the National Downloadable File between January 1, 2018, and December 31, 2020, who participated

assessed a performance penalty, and

in the 2020 MIPS and received a publicly reported final performance score. Data from the 593 863

were less likely to be assessed a bonus

clinicians participating in the 2020 MIPS were used to compare differences in the 2020 MIPS

than other physicians.

performance scores and value-based reimbursement (based on performance in 2018) for

Meaning Psychiatrists performed

psychiatrists vs other physicians, adjusting for physician, patient, and practice area characteristics.

worse than other physicians in
Medicare’s new mandatory outpatient

EXPOSURES Participation in MIPS.

value-based payment system; therefore,
more research is needed to evaluate the

MAIN OUTCOMES AND MEASURES Primary outcomes were final MIPS performance score and
negative (penalty), positive, and exceptional performance bonus payment adjustments. Secondary

appropriateness of MIPS measures for
psychiatrists.

outcomes were scores in the MIPS performance domains: quality, promoting interoperability,
improvement activities, and cost.
RESULTS This study included 9356 psychiatrists (3407 [36.4%] female and 5 949 [63.6%] male)
and 196 306 other outpatient physicians (69 221 [35.3%] female and 127 085 [64.7%] male)
(data on age and race are not available). Compared with other physicians, psychiatrists were less
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likely to be affiliated with a safety-net hospital (2119 [22.6%] vs 64 997 [33.1%]) or a major teaching
hospital (2148 [23.0%] vs 53 321 [27.2%]) and had lower annual Medicare patient volume
(181 vs 437 patients) and mean patient risk scores (1.65 vs 1.78) (P < .001 for all). The mean final MIPS
performance score for psychiatrists was 84.0 vs 89.7 for other physicians (absolute difference,
−5.7; 95% CI, −6.2 to −5.2). A total of 573 psychiatrists (6.1%) received a penalty vs 5739 (2.9%) of
other physicians (absolute difference, 3.2%; 95% CI, 2.8%-3.6%); 8664 psychiatrists (92.6%)
vs 189 037 other physicians (96.3%) received a positive payment adjustment (absolute difference,
−3.7%; 95% CI, −3.3% to −4.1%), and 7672 psychiatrists (82.0%) vs 174 040 other physicians
(88.7%) received a bonus payment adjustment (absolute difference, −6.7%; 95% CI, −6.0% to
−7.3%). These differences remained significant after adjustment.
(continued)
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Abstract (continued)

CONCLUSIONS AND RELEVANCE In this cross-sectional study that compared US psychiatrists with
other outpatient physicians, psychiatrists had significantly lower 2020 MIPS performance scores,
were penalized more frequently, and received fewer bonuses. Policy makers should evaluate
whether current MIPS performance measures appropriately assess the performance of psychiatrists.
JAMA Health Forum. 2022;3(3):e220212. doi:10.1001/jamahealthforum.2022.0212

Introduction
The Merit-Based Incentive Payment System (MIPS) is a mandatory, value-based payment program
implemented by the Centers for Medicare & Medicaid Services (CMS) that covers almost all
outpatient US clinicians who treat Medicare patients. In 2020, the second payment year for MIPS, up
to 5% of clinicians’ Medicare reimbursement was tied to their 2018 performance across 4
measurement domains: quality, promoting interoperability, improvement activities, and cost.1 As the
program is phased in, payment penalties and bonuses will increase to up to 9% of clinicians’ Medicare
reimbursement by the end of 2022.2
The MIPS was designed to assess performance for a broad range of outpatient clinicians,
although different clinicians practice in widely disparate settings and elect to report different quality
measures. Currently, there are 210 MIPS quality measures from which clinicians must select at least
6 to report to the CMS.3,4 This program design may create particular challenges for specialists,5-9
especially those who are unlikely to report common measures, such as hypertension or diabetes
control. There are few MIPS measures specific to specialist practice, and specialists reporting as part
of a multispecialty group or accountable care organization may rely on group reporting of
nonspecialty-specific measures.5,6,10,11 Furthermore, even for specialties for which specific measures
have been developed, these measures may not be usable given the CMS’s plans to phase out
measures with broadly high performance.12 Questions have also been raised about the adequacy of
risk adjustment for the different patient populations seen by different types of specialists.13
Psychiatrists represent one group for whom MIPS may be particularly poorly suited to
adequately assess care quality. Concerns have been raised that there are relatively few well-defined
and widely accepted behavioral health quality measures compared with other medical fields.14,15
Although there were 25 measures in the mental/behavioral health specialty set for 2018, all but 3
were listed in sets for other specialties, suggesting a lack of measures specific to the expertise of
psychiatrists.3 Furthermore, there is currently no adjustment for some of the most prevalent mental
health conditions in quality measures, despite evidence that these disorders are associated with
higher morbidity, mortality, and cost independent of other medical comorbidities.16,17
As financial penalties for nonparticipation or poor performance increase, it is critical to
understand the effect of MIPS on psychiatric practice. This study aims to examine 2 key questions.
First, how did performance scores and payment adjustments assessed under the 2020 MIPS for
psychiatrists compare with those for other outpatient physicians? Second, were there differences in
reporting rates or performance scores on specific performance measures that may help explain these
differences?

Methods
This cross-sectional study was deemed exempt by the Saint Louis University Institutional Review
Board because the data are publicly available on the World Wide Web and are deidentified; therefore,
informed consent was not obtained from the participants. The study followed Strengthening the
Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for crosssectional studies.
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Study Population
We used the CMS Provider Data Catalog to identify outpatient Medicare physicians listed in the
National Downloadable File between January 1, 2018, and December 31, 2020, who participated in
the 2020 MIPS and received a publicly reported final performance score.18 We included physicians
with a listed specialty of primary care, medical specialist, obstetrics-gynecology, or psychiatry, as
defined in the Medicare Data on Provider Practice and Specialty.19 The MIPS data were linked to the
2018 Medicare physician and other supplier reports using physicians’ National Provider
Identifiers (NPIs).

Covariates
Street addresses of practice locations in the National Downloadable File were geocoded and linked
to data from the 2016 American Community Survey, 2018 Area Deprivation Index,20,21 2018
Dartmouth Atlas of Healthcare Hospital Referral Regions, and 2010 US Census tract rural-urban
commuting area codes. We excluded physicians missing data on key variables from the primary
analyses, although we included them in sensitivity analyses to test the robustness of our findings.

Outcomes
Our primary outcomes were physicians’ final performance scores reported under the 2020 MIPS
based on measured performance during 2018, as well as their receipt of negative (penalty), positive,
and exceptional performance bonus payment adjustments. Final performance scores were weighted
composite measures derived from 4 domains: quality (eg, diabetes control), cost of care (eg, total
per capita costs), promoting interoperability (eg, using a certified electronic medical record), and
practice improvement activities (eg, participating in clinical registries). The final performance scores
in the default MIPS track were weighted at 50% for quality, 10% for cost, 25% for promoting
interoperability, and 15% for improvement activities.22
Because some clinicians participated in multiple practices and thus had multiple MIPS
performance scores associated with their NPIs, we used a hierarchy developed by the CMS to assign
scores: physicians participating in a MIPS alternative payment model (APM) were assigned the
highest score received as part of any APM, and physicians not participating in an APM were assigned
the highest score received via any other reporting mechanism.1 Payment adjustments were identified
by applying performance score thresholds established by the CMS for the 2020 MIPS: (1) negative
payment adjustment for performance scores less than 15, (2) positive payment adjustment for
performance scores greater than 15 (a score of exactly 15 received neither a negative nor a positive
payment adjustment), and (3) exceptional bonus payment adjustment for performance scores of 70
or higher.1 In 2020, these values represented adjustments between −5% and +1.68% of clinicians’
total Medicare Part B reimbursement.23 Secondary outcomes were scores in each of the 4 MIPS
performance domains, as well as the top 20 individual MIPS performance measures reported in the
study population.

Physician, Patient, and Practice Area Characteristics
We used the 2018-2020 National Downloadable File and the 2018 Medicare physician and other
supplier reports to identify physician sex, number of years since medical school graduation, Medicare
patient caseload, and mean patient risk scores on the CMS Hierarchical Condition Categories risk
score. Using linked data from the 2018 CMS Impact File, we classified any clinician affiliated with a
safety net hospital (top quartile nationally of disproportionate share hospitals) as a safety net
clinician and any clinician affiliated with a general acute care hospital with a resident-to-bed ratio of
0.25 or greater as being affiliated with a major teaching hospital. We used geocoded data on clinician
practice locations to identify Area Deprivation Index national rank,21 rural vs urban location,24 US
Census region, and Dartmouth hospital referral region.
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Statistical Analysis
We compared physician, patient, and practice area characteristics for psychiatrists vs other
outpatient physicians, using the χ2 test to test for differences in proportions and the independent
sample 2-tailed t test for differences in means. We estimated clinician-level multivariable regression
models to assess the association between psychiatrist vs other physician specialty and the primary
outcomes. We used linear regression for the MIPS final performance score and the 4 domain scores
and logistic regression for the binary payment adjustment outcomes (negative, positive, and bonus
payment adjustment). For each estimate, we report unadjusted results (reflecting current MIPS
methods) as well as results adjusted for the characteristics detailed in Table 1 to control for potential
confounders. We also added market-level fixed effects for 306 Dartmouth hospital referral regions
to estimate within-market associations. We report adjusted results as marginal differences in
dependent variables per unit change in the independent variable.
We conducted an exploratory analysis of the 20 most frequently reported MIPS performance
measures in the study population. We report descriptive statistics on the percentage of clinicians
reporting each measure and their mean performance scores on these measures, comparing
psychiatrists with other physicians. On the basis of prior research, we identified measures that may
be dependent on technology.25
In sensitivity analyses, we compared psychiatrists with other physicians included in our study on
additional patient caseload variables for those who had available data in the 2018 Medicare physician
and other supplier reports. Lastly, we reestimated the models for our primary outcomes, assessing the
same associations among an expanded population of outpatient physicians (adding back those
previously excluded for missing data on key variables) that adjusted for fewer variables and among a
reduced population with more data available on patient caseload that adjusted for additional variables.
We performed all analyses using SAS statistical software, version 9.4 (SAS Institute Inc) and
Stata software, version 15.1 (StataCorp). A 2-sided P < .05 was considered to be statistically
significant.

Results
Study Population
Of the 593 863 clinicians listed in the National Downloadable File in 2018 to 2020 participating in the
2020 MIPS, 359 483 were excluded because their primary specialty was not primary care, a medical
specialty, obstetrics-gynecology, or psychiatry (Figure 1). Of the remaining clinicians, we excluded 198
whose practice locations could not be geocoded and 26 520 who were missing data on key variables.
Our final study population consisted of 205 662 clinicians, including 9356 psychiatrists (3407 [36.4%]
female and 5 949 [63.6%] male) and 196 306 other physicians (69 221 [35.3%] female and 127 085
[64.7%] male) (data on age and race are not available). Compared with physicians included in the study,
those excluded were more likely to be psychiatrists (213 [8.9%] vs 426 [4.5%]) or medical specialists
(15 151 [56.7%] vs 100 926 [49.1%]) and had a lower mean patient caseload (290 [383] vs 425 [484]
patients) (eTable 1 in the Supplement). Psychiatrists were less likely to participate in MIPS in 2018 than
other outpatient physicians in the National Downloadable File who billed Medicare during 2018 to
2020 (11 730 [41.1%] vs 221 118 [59.1%]) (eTable 2 in the Supplement).
Psychiatrists were less likely than other physicians to be affiliated with a safety net (2119
[22.6%] vs 64 997 [33.1%]) or major teaching hospital (2148 [23.0%] vs 53 321 [27.2%]) or have a
rural practice location (1325 [14.2%] vs 31 758 [16.2%]) and had lower annual Medicare patient
caseloads (181 vs 437) and hierarchical condition category scores (1.65 vs 1.78) (Table 1). Psychiatrists
also treated patients who had a younger mean (SD) age (59.6 [8.9] vs 71.8 [5.1] years) and saw a
markedly higher proportion of patients with diagnosed depression (69.1% vs 29.9%) or dual
enrollment in Medicaid (56.6% vs 26.7%). Psychiatrists’ patients were also more often male (45.0%
vs 40.7%) and races other than white (27.0% vs 22.3%) (eTable 3 in the Supplement).
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Comparison of Psychiatrists With Other Outpatient Physicians
on Overall MIPS Performance
The mean (SD) MIPS final performance score for physicians in our study was 89.4 (23.7), with 6312
(3.1%) receiving negative payment adjustments, 197 700 (96.1%) receiving positive payment
adjustments, and 181 712 (88.4%) receiving bonus payment adjustments (eTable 1 in the
Supplement). The mean (SD) MIPS final performance score for psychiatrists was lower than other
physicians (84.0 [29.7] vs 89.7 [23.3]; absolute difference, −5.7; 95% CI, −6.2 to −5.2) (Table 2). The

Table 1. Characteristics of Psychiatrists and Other Outpatient Physicians
Participating in the 2020 Medicare Merit-Based Incentive Payment Systema
Psychiatrists
(n = 9356)b

Other outpatient
physicians
(n = 196 306)

Female

3407 (36.4)

69 221 (35.3)

Male

5949 (63.6)

127 085 (64.7)

Time since medical school graduation, mean (SD), y

24 (13)

23 (12)

Primary care physicianc

0

104 736 (53.4)

Specialistd

9356 (100)

91 570 (46.6)

Affiliated with a safety net hospital

2119 (22.6)

64 997 (33.1)

<.001

Affiliated with a major teaching hospital

2148 (23.0)

53 321 (27.2)

<.001

Total Medicare beneficiaries, mean (SD)e

181 (219)

437 (490)

<.001

CMS-HCC Risk Score, mean (SD)f

1.65 (0.49)

1.78 (0.87)

<.001

Area Deprivation Index national rank, mean (SD)h

46 (28)

45 (26)

<.001

Rural

1325 (14.2)

31 758 (16.2)

<.001

Urban

8619 (92.1)

177 442 (90.4)

<.001

Northeast

2817 (30.1)

43 042 (21.9)

South

2896 (31.0)

73 373 (37.4)

Midwest

2206 (23.6)

43 813 (22.3)

West

1436 (15.3)

36 072 (18.4)

Other

0

0

Characteristic

P value

Physician characteristics
Sex
.02
<.001
NA

Medicare patient caseload characteristics

Local practice area characteristicsg

US Census region

<.001

Abbreviations: CMS, Centers for Medicare & Medicaid Services; HCC, hierarchical condition categories; NA, not applicable.
a

Data are presented as number (percentage) of physicians unless otherwise indicated.

b

Includes all physicians who listed a primary or secondary specialty of psychiatry, geriatric psychiatry, or neuropsychiatry.

c

Includes all physicians who listed a medical specialty of geriatric medicine, internal medicine, family medicine, general
practice, obstetrics-gynecology, or pediatric medicine.

d

Includes all physicians who were not primary care physicians.

e

Seen as patients in 2018 as reported in the Medicare Physician and Other Supplier Reports. Because of extreme outliers
in this data set, we winsorized this number before analysis using the entire distribution in the sample, setting the bottom
1% equal to the first percentile value (n = 14) and the top 1% equal to the 99th percentile value (n = 2279).

f

Based on patients’ age, sex, original reason for Medicare eligibility, dual Medicaid enrollment, institutionalization in longterm care, and 83 clinical conditions identified by diagnoses in Medicare claims. Higher scores imply sicker and highercost patients. The CMS-HCC risk score ranges from 0.43 to 10.07 in our population, with an IQR of 1.15 to 2.19 and a
median of 1.55. A mean score of 1.78 implies a patient caseload 78% sicker than the national average.

g

Note that many clinicians have multiple practice locations. As a result, the Area Deprivation Index national rank
represents the mean for each clinician across all their practice locations. In addition, some clinicians had practice
locations in both rural and urban areas, and others had practice locations in more than 1 US Census region; thus, these
numbers do not sum to 100%.

h

A measure of local neighborhood area socioeconomic disadvantage derived from US Census tract data on income,
educational level, employment, and housing quality, the Area Deprivation Index national rank ranges from 0 to 100 and
indicates the percentile rank of disadvantage for a given US Census tract. Numbers closer to 100 indicate greater
disadvantage. Numbers closer to 50 are indicative of the national mean.
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number of psychiatrists who received a negative payment adjustment was 573 (6.1%) vs 5 739
(2.9%) for other physicians (absolute difference, 3.2%; 95% CI, 2.8%-3.6%); 8664 (92.6%) of
psychiatrists vs 189 037 (96.3%) of other physicians received a positive payment adjustment
(absolute difference, −3.7%; 95% CI, −4.1% to −3.3%), and 7672 (82.0%) of psychiatrists vs 174 040
(88.7%) of other physicians received a bonus payment adjustment (absolute difference, −6.7%; 95%
CI, −7.3% to −6.0%).
After adjustment, compared with other physicians, psychiatrists had lower MIPS final
performance scores (difference, −6.3; 95% CI, −6.8 to −5.9), higher likelihood of receiving a negative
payment adjustment (difference, 2.1%; 95% CI, 1.8% to 2.5%), and lower likelihoods of receiving a
positive (difference, −2.9%; 95% CI, −3.3% to −2.5%) or bonus (difference, −6.9%; 95% CI, −7.7% to
−6.2%) payment adjustment.
Results were similar in sensitivity analyses of the primary outcomes among an expanded
population that included physicians with missing data and among a reduced population of physicians

Figure 1. Study Sample Selection Flowchart
591 863 Clinicians listed in the National Downloadable File for 2018-2020
with publicly reported 2020 MIPS performance scores
359 483 Excluded because their primary specialty
was not primary care
178 531 Nonphysician clinicians
71 442 Surgeons
109 510 Hospital-based specialists

11 741 Psychiatrists

220 639 Nonpsychiatrist outpatient physician
198 Excluded for practice locations that could
not be geocoded
18 Psychiatrists
180 Nonpsychiatrist outpatient physicians

11 723 Psychiatrists

220 459 Nonpsychiatrist outpatient physician
26 520 Missing Data
14 337 Area Deprivation Index data
86 Dartmouth hospital referral region data
4 US Census tract rural urban commuting area
11 194 Medicare physician and other supplier reports
899 Years since medical school graduation

9356 Psychiatrists

MIPS indicates Merit-Based Incentive
Payment System.

196 306 Nonpsychiatrist outpatient physician

Table 2. Association of Psychiatry vs Other Outpatient Physician Specialty Type With 2020 Merit-Based Incentive Payment System Performance Scores
Adjusted resultsa

Unadjusted results

a

Absolute difference
(95% CI)

Marginal difference of psychiatry
vs other specialty
(95% CI)b

Relative difference of psychiatry
vs other specialty, %
(95% CI)c

89.6 (23.3)

−5.6 (−6.1 to −5.1)

−6.3 (−6.8 to −5.8)

−7.1 (−7.6 to −6.5)

5739 (2.9)

3.2 (2.8 to 3.6)

2.1 (1.8 to 2.5)

69.6 (58.7 to 80.4)

8663 (92.6)

189 037 (96.3)

−3.7 (−4.1 to −3.3)

−2.9 (−3.3 to −2.5)

−3.1 (−3.5 to −2.6)

7672 (82.0)

174 040 (88.7)

−6.7 (−7.3 to −6.0)

−6.9 (−7.7 to −6.2)

−7.9 (−8.7 to −7.0)

Variable

Psychiatrists
(n = 9356)

Other outpatient
physicians
(n = 196 306)

Final performance score, mean (SD)

84.0 (29.7)

Negative payment adjustment, No. (%)

573 (6.1)

Positive payment adjustment, No. (%)
Bonus payment adjustment, No. (%)

Multivariable regression models were used to estimate the findings, which also
adjusted for the physician, patient caseload, and local practice area characteristics
listed in Table 1 (with the exception of primary care/specialist status) and with the
addition of fixed effects for Dartmouth hospital referral regions. Ordinary least-squares
regression was used to model the final performance score outcome and logistic
regression to model the 3 binary payment adjustment indicators.

b

The marginal differences in the outcome are reported as the change in the mean of the
dependent variables associated with a unit change in the independent variables (ie,
the marginal effect).

c

The relative differences in the outcome are reported as the marginal difference divided
by the study population mean.
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that adjusted for the additional patient caseload variables of dual Medicaid enrollment, age, sex, and
race (eTable 4 in the Supplement). The magnitude of differences was greater in the reduced
population, although this finding was consistent with or without adjusting for the additional
variables.

Comparison of Psychiatrists With Other Outpatient Physicians
on MIPS Domain Score Performance
In secondary analyses, compared with other physicians, psychiatrists had lower adjusted means
across all 4 of the 2020 MIPS domain scores. The largest absolute differences were in the quality
(adjusted mean, 79.6 vs 86.7) and promoting interoperability (adjusted mean, 83.5 vs 90.1) domain
scores (Figure 2; eTable 5 in the Supplement).

Exploratory Analysis of the Top 20 Individual MIPS Performance Measures
The top 20 measures reported by the study population are listed in Table 3. The most frequently
reported measures were identical among psychiatrists and nonpsychiatrists and were largely
unrelated or nonspecific to psychiatric practice. Of the top 20 measures, only 5 are included in the
mental/behavioral health specialty set, all of which are also in the specialty sets for internal medicine
and family medicine.
Psychiatrists had similar-to-lower reporting rates and performance scores on technologydependent MIPS performance measures. Psychiatrists were significantly less likely to report
participating in a health information exchange (4651 [49.7%] vs 107 834 [54.9%]; absolute
difference, −5.3%; 95% CI, −6.3% to −4.2%) and had lower mean (SD) performance scores (22.8
[22.2] vs 25.5 [23.8]; absolute difference, −2.8; 95% CI, −3.5 to −2.1).
For nontechnology-dependent measures, psychiatrists reported at higher rates than other
clinicians on 13 of 15 measures but had lower mean (SD) performance scores on 8 of 15 measures,
including documentation of current medications (80.8 [20.1] vs 89.5 [14.1]; absolute difference, −8.7;
95% CI, −9.3 to −8.2), colorectal cancer screening (48.4 [19.7] vs 51.9 [20.0]; absolute difference,
−3.4; 95% CI, −4.2 to 2.6), and breast cancer screening (53.7 [19.6] vs 57.1 [18.4]; absolute difference,
−3.4; 95% CI, −4.2 to −2.6). However, among the measures that appear most relevant to the practice
of psychiatry, psychiatrists had higher reporting rates and better performance, including for
depression screening and follow-up (reporting rate, 2542 [27.2%] vs 36 157 [18.4%]; absolute
difference, 8.8%; 95% CI, 7.9%-9.6%; mean [SD] performance score, 43.4 [28.5] vs 40.9 [27.7];
absolute difference, 2.5; 95% CI, 1.4-3.6), screening for future fall risk (reporting rate, 2599 [27.8%]
vs 43 885 [22.3%]; absolute difference, 5.4%; 95% CI, 4.6%-6.3%; mean [SD] performance score,
63.2 [27.3] vs 58.4 [29.2]; absolute difference, 4.8; 95% CI, 3.7-6.0), and use of the PHQ-9 tool for

Figure 2. Differences in 2020 Risk-Adjusted US Medicare Merit-Based Incentive Payment System (MIPS)
Domain Scores for Psychiatrists vs Other Outpatient Physicians

Adjusted means of 2020 MIPS
domain scores

100

P <.001

P <.001

Psychiatrists
P <.001

80

Other outpatient
physicians

60
P <.001
40

20

0
Quality score

Promoting
interoperability score

Improvement
activities score

Cost score
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depression screening (reporting rate, 1171 [12.5%] vs 17 062 [8.7%]; absolute difference, 3.8%; 95%
CI, 3.2%-4.4%; mean [SD] total performance score, 26.1 [20.9] vs 24.8 [17.5]; absolute difference,
1.3; 95% CI, 0.3-2.4).
Finally, of the 25 MIPS measures included in the mental/behavioral health specialty (eTable 6 in
the Supplement), we found that 13 measures were reported by less than 2% of psychiatrists, and 7
measures were not reported by any physicians in our sample.

Discussion
In this cross-sectional study comparing psychiatrists with other outpatient physicians in the 2020
Medicare MIPS, psychiatrists had significantly lower performance scores and, consequently, were
more likely to be penalized and less likely to receive bonus payments than their peers. These

Table 3. Comparison of the Top 20 Merit-Based Incentive Payment System Performance Measures Publicly Reported for 2020 in the Study Populationa
Physicians reporting, No. (%)b

Variable

All physicians
(n = 205 662)

Psychiatrists
(n = 9356)

Performance scores, mean (SD)c
Other outpatient
physicians
(n = 196 306)

Absolute difference
(95% CI)

Psychiatrists

Other
outpatient
physicians

Absolute difference
(95% CI)

Technology-dependent measures
Provide patient access

145 077 (70.5)

6622 (70.8)

138 455 (70.5)

0.3 (−0.6 to 1.3)

84.0 (21.8)

83.8 (20.5)

0.1 (−0.4 to 0.7)

Electronic prescribing

144 194 (70.1)

6583 (70.4)

137 611 (70.1)

0.3 (−0.7 to 1.2)

90.6 (12.5)

90.8 (12.0)

−0.2 (−0.5 to 0.1)

Secure messaging

141 049 (68.6)

6362 (68.0)

134 687 (68.6)

−0.6 (−1.5 to 0.4)

25.4 (18.8)

27.1 (20.0)

−1.6 (−2.1 to −1.1)

Health information exchange

112 485 (54.7)

4651 (49.7)

107 834 (54.9)

−5.3 (−6.3 to −4.2)

22.8 (22.2)

25.5 (23.8)

−2.8 (−3.5 to −2.1)

View, download, or transmit

67 396 (32.8)

3028 (32.4)

64 368 (32.8)

−0.6 (−1.6 to 0.4)

24.9 (18.2)

26.8 (19.3)

−1.8 (−2.5 to −1.1)

Nontechnology-dependent measures
Patient-specific educational level

143 440 (69.7)

6461 (69.1)

136 979 (69.8)

−0.7 (−1.6 to 0.3)

71.6 (30.4)

69.0 (31.0)

2.6 (1.9 to 3.4)

Medication reconciliation

120 311 (58.5)

5368 (57.4)

114 943 (58.6)

−1.3 (−2.3 to −0.3)

83.6 (15.6)

86.3 (15.7)

−2.7 (−3.1 to −2.3)

Preventive care and screening:
body mass index screening and
follow-up plan

54 714 (26.6)

3157 (33.7)

51 557 (26.3)

7.5 (6.6 to 8.5)

50.4 (23.9)

53.3 (24.2)

−2.9 (−3.8 to −2.1)

Pneumococcal vaccination status
for older adults

54 622 (26.6)

2759 (29.5)

51 863 (26.4)

3.2 (2.3 to 4.1)

60.4 (22.9)

61.7 (22.2)

−1.3 (−2.2 to −0.5)

Documentation of current
medications in the medical record

52 491 (25.5)

2649 (28.3)

49 842 (25.4)

2.9 (2.0 to 3.8)

80.8 (20.1)

89.5 (14.1)

−8.7 (−9.3 to −8.2)

Breast cancer screening

48 132 (23.4)

2553 (27.3)

45 579 (23.2)

4.1 (3.2 to 5.0)

53.7 (19.6)

57.1 (18.4)

−3.4 (−4.1 to −2.7)

Colorectal cancer screening

46 935 (22.8)

2388 (25.5)

44 547 (22.7)

2.9 (2.0 to 3.8)

48.4 (19.7)

51.8 (20.0)

−3.5 (−4.3 to −2.6)

Falls: screening for future fall risk

46 484 (22.6)

2599 (27.8)

43 885 (22.4)

5.5 (4.6 to 6.4)

63.2 (27.3)

58.4 (29.2)

4.8 (3.6 to 5.9)

Preventive care and screening:
influenza immunization

44 324 (21.6)

2516 (26.9)

41 808 (21.3)

5.6 (4.8 to 6.5)

45.3 (21.1)

47.1 (21.8)

−1.8 (−2.6 to −0.9)

Ischemic vascular disease: use of
aspirin or another antiplatelet

41 741 (20.3)

1991 (21.3)

39 750 (20.2)

1.0 (0.2 to 1.9)

81.0 (8.4)

80.7 (10.5)

0.3 (−0.2 to 0.8)

Tobacco use: screening and
cessation intervention

41 442 (20.2)

2375 (25.4)

39 067 (19.9)

5.5 (4.7 to 6.4)

66.2 (31.8)

67.4 (33.0)

−1.2 (−2.5 to 0.2)

Screening for depression and
follow-up plan

38 699 (18.8)

2542 (27.2)

36 157 (18.4)

8.8 (8.0 to 9.6)

43.4 (28.5)

40.9 (27.7)

2.5 (1.4 to 3.6)

Use of high-risk medications
in the elderly

33 722 (16.4)

1765 (18.9)

31 957 (16.3)

2.5 (1.8 to 3.3)

8.2 (7.1)

6.1 (6.5)

2.0 (1.7 to 2.3)

Weight assessment and counseling
for nutrition and physical activity
for children and adolescents

24 739 (12.0)

1555 (16.6)

23 184 (11.8)

4.9 (4.2 to 5.5)

46.6 (36.2)

49.8 (35.8)

−3.4 (−5.2 to −1.6)

Depression utilization
of the PHQ-9 tool

18 233 (8.9)

1171 (12.5)

17 062 (8.7)

3.8 (3.2 to 4.4)

26.1 (20.9)

24.8 (17.5)

1.2 (0.1 to 2.2)

Preventive care and screening

measures (although they did all have an overall MIPS score and payment adjustment
reported).

Abbreviation: PHQ-9, Patient Health Questionnaire 9.
a

b

This table displays an exploratory analysis of reporting on individual performance
measures to explore potential underlying mechanisms of performance score
differences between psychiatrists and other outpatient physicians.
Physicians who met the study inclusion and exclusion criteria and had data publicly
reported on individual Merit-Based Incentive Payment System (MIPS) measures. Note
that not all physicians included in our study had data publicly reported on individual

c

Mean performance scores of physicians with publicly reported measure data, as
indicated in the number (percentage) reporting. To get the number of physicians
reporting for mean performance scores, multiply the percentage reporting by the total
number of physicians in the study population for each measure.
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performance disparities were driven primarily by lower scores in the quality and promoting
interoperability domains. In particular, psychiatrists performed more poorly on technologydependent measures, such as participation in health information exchanges; care coordination
measures, such as documentation of patient medications in medical records; and preventive care
measures unrelated to psychiatry, such as cancer screening.
Taken together, our findings imply that psychiatrists may not be as well prepared as other
outpatient physicians for the reporting and performance requirements of the MIPS program and may
experience financial penalties as a result. As the size of value-based payment adjustments increases
in MIPS in future years,26 in concert with increasing demand for psychiatric services from the aging
Medicare population,27 psychiatric practitioners may experience significant financial implications.
Many psychiatric practices already face low visit payment rates and narrow network restrictions28-31
in the Medicaid, Medicare Advantage, and commercial insurance markets. Psychiatrists are also
substantially less likely to accept Medicare than any other nonpediatric physicians.32-35 The increased
administrative and financial burdens introduced by MIPS may further disincentivize psychiatrists
from treating Medicare patients,33 resulting in an even greater number of psychiatrists who require
patients to pay out of pocket for services. This factor has concerning implications for access to mental
health care for Medicare beneficiaries.
Our findings also raise additional questions about the relevance and appropriateness of the
MIPS program for performance assessment of specialists.5-12 Ideally, each specialty would be judged
on measures of greatest relevance to the patients treated by that specialty. For instance, within
psychiatry, we would expect quality measures for evidence-based pharmaceutical treatment,
appropriate referral to cognitive-behavioral therapy, and coordination and integration of services
with primary care physicians.36-39 The fact that just as many psychiatrists in our exploratory analysis
reported on quality measures for cancer screening and flu shots as for depression care suggests that
MIPS performance reflects multispecialty group performance as opposed to quality of psychiatric
care. Our finding that most measures included in the mental/behavioral health specialty set were
almost entirely unreported indicates that further efforts are needed to develop and encourage use
of measures relevant to psychiatric care.
Psychiatrists may also face greater challenges than other outpatient physicians because they
are more likely to treat a caseload that includes a higher proportion of socially at-risk patients.27 We
found that psychiatrists were more than twice as likely to treat patients dually enrolled in Medicaid
and treat greater numbers of patients with disabilities or who belong to racial and ethnic minority
groups. Prior research shows that Medicare clinicians with larger caseloads of patients with these
characteristics perform worse on the MIPS and other value-based payment programs, perhaps
because of inadequate risk adjustment for social risk factors.40-42 In addition, Medicare does not risk
adjust for the most prevalent forms of depression and anxiety disorders, and prior research shows
that this inadequate risk adjustment results in underestimation of the resources required to treat
beneficiaries with these conditions.42,43 Treating patients with more social risk factors further
increases the complexity of psychiatric visits and requires more resources for treatment,
compounding the increased costs of caring for patients with mental health disorders.17 As a result,
the CMS should track the effect of the MIPS program on the Part B participation rates of psychiatrists
and other clinicians who disproportionately provide care for beneficiaries with social and mental
health risk factors to ensure that basic levels of access to behavioral health care are maintained.
Whether the MIPS will meaningfully improve quality of psychiatric care for Medicare patients is
unknown. Research on the first year of the MIPS program suggests that the quality-of-care measures
reported to the CMS by physicians may be better explained by selective reporting behaviors
designed to maximize reimbursement as opposed to actual quality of care.9,25,44,45 Longer-term
studies are needed as future years of data become available to examine the effect of MIPS on
psychiatry and behavioral health.
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Limitations
This study has several limitations. First, this study was dependent on publicly reported data from the
CMS in the National Downloadable Files and MIPS data sets. The CMS did not publicly report MIPS
performance data on low-volume MIPS-participating clinicians, and very low-volume Medicare
physicians and those who participated in advanced APMs that shared financial risk with the CMS
were excluded from the MIPS entirely. Second, we identified physicians by their unique NPIs,
although the CMS identifies physicians in the MIPS by their unique NPI and tax identifier number
combinations, counting the same physician multiple times. As a result, our participation counts are
lower than those of the CMS. Third, this was an observational study; although the adjusted analysis
controlled for multiple physician, caseload, and practice area factors, it is likely there is residual
unmeasured confounding. More research is needed to uncover the causal mechanisms behind
these findings.

Conclusions
In this national cross-sectional study of Medicare psychiatrists and other outpatient physicians
participating in the 2020 MIPS, psychiatrists received significantly lower performance scores, were
penalized more frequently, and received fewer bonus payments than other outpatient physicians.
The CMS may want to reconsider the use of many current MIPS measures for assessing the
performance of psychiatrists.
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